Alpha Tau Medical Ltd.
NASDAQ:DRTS
3.1 (USD) • At close December 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Assets: | |||||
| Current Assets: | |||||
| Cash & Cash Equivalents
| 12.657 | 5.836 | 23.236 | 15.598 | 1.831 |
| Short Term Investments
| 69.131 | 98.694 | 8.08 | 30.417 | 26.298 |
| Cash and Short Term Investments
| 81.788 | 104.53 | 31.316 | 46.015 | 28.129 |
| Net Receivables
| 0.019 | 0 | 0 | 0 | 0.564 |
| Inventory
| -0.019 | -1.065 | -8.169 | -29.846 | 1.132 |
| Other Current Assets
| 3.968 | 1.947 | 1.325 | 1.44 | 1.698 |
| Total Current Assets
| 85.756 | 106.477 | 32.641 | 47.455 | 29.827 |
| Non-Current Assets: | |||||
| Property, Plant & Equipment, Net
| 21.161 | 13.281 | 7.546 | 5.395 | 1.714 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.471 | 0.391 | 2.028 | 0.139 | 0.016 |
| Total Non-Current Assets
| 21.632 | 13.672 | 9.574 | 5.534 | 1.73 |
| Total Assets
| 107.388 | 120.149 | 42.215 | 52.989 | 31.557 |
| Liabilities & Equity: | |||||
| Current Liabilities: | |||||
| Account Payables
| 2.566 | 1.423 | 1.203 | 0.964 | 0.893 |
| Short Term Debt
| 1.062 | 1.338 | 0 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 3.474 | 1.577 | 3.202 | 1.124 | 0.456 |
| Total Current Liabilities
| 7.102 | 4.338 | 4.405 | 2.088 | 1.349 |
| Non-Current Liabilities: | |||||
| Long Term Debt
| 12.214 | 4.524 | 0 | 53.964 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 3.597 | 5.63 | 72.587 | 5.366 | 30.401 |
| Total Non-Current Liabilities
| 15.811 | 10.154 | 72.587 | 59.33 | 30.401 |
| Total Liabilities
| 22.913 | 14.492 | 76.992 | 61.418 | 31.75 |
| Equity: | |||||
| Preferred Stock
| 0 | 0 | 0.073 | 0.059 | 0.03 |
| Common Stock
| 0 | 0 | 0 | 0.001 | 0 |
| Retained Earnings
| -115.759 | -86.602 | -52.84 | -25.569 | -16.687 |
| Accumulated Other Comprehensive Income/Loss
| -0 | 0 | 0 | -0.06 | 0 |
| Other Total Stockholders Equity
| 200.234 | 192.259 | 18.063 | 17.2 | 16.494 |
| Total Shareholders Equity
| 84.475 | 105.657 | -34.777 | -8.429 | -0.193 |
| Total Equity
| 84.475 | 105.657 | -34.777 | -8.429 | -0.193 |
| Total Liabilities & Shareholders Equity
| 107.388 | 120.149 | 42.215 | 52.989 | 31.557 |